Xerosis and callus formation as a key to the diabetic foot syndrome: Dermatologic view of the problem and its management;Xerosis und kallusformation als schlüssel für das diabetische fußsyndrom: Problemstellung und management aus dermatologischer sicht

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 11, 2006, Pages 935-941

  Pavicic, Tatjana ^a,b   Korting, Hans Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Callus; Diabetes mellitus; Diabetic neuropathy; Peripheral arterial occlusion; Plantar foot pressure; Urea

Indexed keywords

AMMONIUM LACTATE; CARMOL; CICLOPIROX; UREA;

CALLUS; DIABETIC FOOT; FOOT CARE; HUMAN; INCIDENCE; MYCOSIS; REVIEW; RISK FACTOR; SKIN DEFECT; SKIN FISSURE; XEROSIS;

CALLOSITIES; DERMATOLOGY; DIABETIC FOOT; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESSURE ULCER; SYNDROME;

EID: 33750565172     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.06123.x     Document Type: Review

References (47)

1. Morbach S, Lutale JK, Viswanathan V, Möllenberg J, Ochs HR, Rajashekar S, Ramachandran A, Abbas ZG. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med 2004; 21: 91-95.
2. Kästenbauer T, Irsigler K. Das diabetische Fußsyndrom. Wien Med Wochenschr 2003;153: 474-477.
3. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, Holle R. Predictors of 10-year microvascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 1996; 39: 1540-1545.
4. Trautner C, Haastert B, Spraul M. Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diabet Care 2001; 24: 855-859.
5. Frykberg RG. The team approach in diabetic foot management. Adv Wound Care 1998; 11: 71-77.
6. Boulton AJ, Meneses P, Ennis EJ. Diabetic foot ulcers: a framework for prevention and care. Wound Rep Reg 1999; 7: 7-16.
7. Lobmann R, Kasten G, Kasten U, Lehnert H. Association of increased plantar pressures with peripheral sensorimotor and peripheral autonomic neuropathy in Type 2 diabetic patients. Diabetes Nutr Metab 2002; 15: 165-168.
8. Stiegler H. Das diabetische Fußsyndrom. Herz 2004; 29: 104-115.
9. Melton LJ 3rd, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980; 3: 650-654.
10. Pataky Z, Golay A, Bounameaux H, Bobbioni-Harsch E, Assal JP. Relationship between peripheral vascular disease and high plantar pressures in diabetic neuro-ischaemic patients. Diabetes Metab 2003; 29: 489-495.
11. Ward JD, MacKinnon M. Diabetes Care. Qual Health Care 1992; 1: 260-265.
12. Reiber GE, Vileikyte L, Boyko EJ. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22: 157-162.
13. Frykberg RG, Veves A. Diabetic foot infections. Diabetes Metab Rev 1996; 12: 255-270.
14. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 289-292.
15. Schie van CH. A review of the biomechanics of the diabetic foot. Int J Low Extrem Wounds 2005; 4: 160-170.
16. Gefen A. Plantar soft tissue loading under the medial metatarsals in the standing diabetic foot. Med Engineering Physics 2003; 25: 491-499.
17. Barnett SJ, Shield JPH, Potter MJ, Baum JD. Foot pathology in insulin dependent diabetes. Arch Disease Childhood 1995; 73: 151-153.
18. Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992; 35: 660-663.
19. Ahroni JH, Boyko EJ, Forsberg RC. Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care 1999; 22: 965-972.
20. Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996; 13: 979-982.
21. Ctercteko GC, Dhanendran M, Hutton WC. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981; 68: 608-614.
22. Abouaesha F, van Schie CHM, Griffths GD. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care 2001; 24: 1270-1274.
23. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med 1992; 9: 55-57.
24. Pataky Z, Golay A, Bounameaux H, Bobbioni-Harsch E, Assal JP. Relationship between peripheral vascular disease and high plantar pressures in diabetic neuro-ischaemic patients. Diabetes Metab 2004; 30: 201.
25. Thomas SE, Dykes PJ, Marks R. Plantar hyperkeratosis: a study of callosities and normal plantar skin. J Invest Dermatol 1985; 85: 394-397.
26. Collier JH, Brodbeck CA. Assessing the diabetic foot: plantar callus and pressure sensation. Diabetes Educ 1993; 19: 503-508.
27. Pitei DL, Foster A, Edmonds M. The effect of regular callus removal on foot pressures. J Foot Ankle Surg 1999; 38: 251-255.
28. Buckingham B, Perejda AJ, Sandborg C, Kershnar AK, Uitto J. Skin, joint, and pulmonary changes in type I diabetes mellitus. Am J Dis Child 1986; 140: 420-423.
29. Duffin AC, Lam A, Kidd R, Chan AKF, Donaghue KC. Ultrasonography of plantar soft tissues thickness in young people with diabetes. Diabet Med 2002; 19: 1009-1013.
30. Hashmi F, Malone-Lee J, Hounsell E. Plantar skin in type II diabetes: an investigation of protein glycation and biomechanical properties of plantar epidermis. Eur J Dermatol 2006; 16: 23-32.
31. Colagiuri S, Marsden LL, Naidu V, Taylor L. The use of orthotic devices to correct plantar callus in people with diabetes. Diabet Res Clin Pract 1995; 28: 29-34.
32. Crane M, Branch P. The healed diabetic foot. What next? Clin Podiatr Med Surg 1998; 15: 155-174.
33. Garrow AP, van Schie CHM, Boulton AJM. Efficacy of multilayered hosiery in reducing in-shoe plantar foot pressure in high-risk patients with diabetes. Diabetes Care 2005; 28: 2001-2005.
34. Duffin AC, Kidd R, Chan A, Donaghue KC. High plantar pressure and callus I diabetic adolescents. Incidence and treatment. J Am Podiatr Med Assoc 2003; 93: 214-220.
35. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485-491.
36. Litzelman DK, Marriott DJ, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM. Conventional wisdom or evidence-based practice? Diabetes Care 1997; 20: 156-162.
37. Yosipovitch G, Hodak E, Vardi P, Sharga I, Karp M, Sprecher E, David M. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998; 21: 506-509.
38. Rich P, Hare A. Onychomycosis in a special patient population: focus on the diabetic. Int J Derm 1999; 38 (Suppl 2): 17-19.
39. Mayser P, Hensel J, Thoma W, Podobinska M, Geiger M, Ulbricht H, Haak T. Prevalence of fungal foot infections in patients with diabetes mellitus type 1 - underestimation of moccasin-type tinea. Exp Clin Endocrinol Diabetes 2004; 112: 264-268.
40. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol 2000; 10: 379-384.
41. Pham HT, Exelbert L, Segal-Owens AC, Veves A. A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Management 2002; 48: 30-36.
42. Ademola J, Frazier C, Kim SJ, Theaux C, Saudez X. Clinical evaluation of 40 % urea and 12 % ammonium lactate in the treatment of xerosis. Am J Clin Dermatol 2002; 3: 217-222.
43. Loden M. Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 1996; 288: 103-107.
44. Gisold EM, Hneyon G, Grossman RM. A clinical evaluation of Urexine® moisturizer creams in the treatment of xerosis. Cosmet Dermatol 1988; 5: 19-24.
45. Elewski BE, Haley HR, Robbins CM. The use of 40 % urea cream in the treatment of moccasin tinea pedis. Cutis 2004; 73: 355-357.
46. Leyden JL. Tinea pedis pathophysiology and treatment. J Am Acad Dematol 1994; 31 (Suppl 3): 31-33.
47. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004; 47: 1343-1353.